Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 30 07 2021
revised: 09 08 2021
accepted: 15 08 2021
pubmed: 30 8 2021
medline: 17 12 2021
entrez: 29 8 2021
Statut: ppublish

Résumé

The prognostic value of oligoclonal bands in the cerebrospinal fluid of Multiple Sclerosis (MS) patients is controversial. While several studies have demonstrated a worse disease course in OCB positive patients, others did not reproduce these findings. We evaluated the prognostic significance of OCB retrospectively based on clinical records of OCB status upon diagnosis and severity outcomes including the MS Severity Score, Progression Index and regional involvement in Magnetic Resonance Imaging. OCB positive patients had a higher median MSSS and PI, and a greater proportion of spinal cord involvement. These findings provide further evidence of the prognostic importance of OCB in MS patients.

Identifiants

pubmed: 34455137
pii: S2211-0348(21)00487-9
doi: 10.1016/j.msard.2021.103220
pii:
doi:

Substances chimiques

Oligoclonal Bands 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

103220

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

G Ben Noon (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: gil.bnoon@gmail.com.

I Vigiser (I)

Neuroimmunology and Multiple Sclerosis Unit of the Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

T Shiner (T)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Sagol School of Neuroscience Tel Aviv University, Tel Aviv, Israel.

H Kolb (H)

Neuroimmunology and Multiple Sclerosis Unit of the Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

A Karni (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Neuroimmunology and Multiple Sclerosis Unit of the Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sagol School of Neuroscience Tel Aviv University, Tel Aviv, Israel.

K Regev (K)

Neuroimmunology and Multiple Sclerosis Unit of the Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH